Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Aerosol: SOP for Handling Deviations in Manufacturing – V 2.0

Posted on By

Aerosol: SOP for Handling Deviations in Manufacturing – V 2.0

SOP for Handling Deviations in Manufacturing

Department Aerosol
SOP No. SOP/Aerosol/036/2025
Supersedes SOP/Aerosol/036/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) defines the process for identifying, documenting, investigating, and resolving deviations that occur during aerosol manufacturing. The purpose of this SOP is to ensure that all deviations are managed systematically, corrective actions are implemented promptly, and product quality is not compromised. By following this SOP, the company ensures compliance with Good Manufacturing Practices (GMP) and regulatory requirements.

2. Scope

This SOP applies to all deviations encountered during the aerosol manufacturing process, including formulation, filling, packaging, and other related stages. It covers the process for managing deviations that may affect product quality, safety, or compliance with regulatory standards. This SOP does not cover routine equipment malfunctions, which are addressed in separate maintenance procedures.

3. Responsibilities

  • Production Team: Responsible for identifying deviations during the manufacturing process, reporting them, and implementing immediate corrective actions as necessary.
  • Quality Control (QC) Team: Responsible for investigating deviations, ensuring that corrective actions are taken, and verifying that the root cause has been addressed.
  • Maintenance Team: Responsible for addressing any deviations related to equipment malfunctions, ensuring that the equipment is functioning correctly to prevent further
deviations.
  • Quality Assurance (QA) Team: Responsible for overseeing the deviation management process, ensuring that all deviations are documented, investigated, and resolved according to GMP standards.
  • Health and Safety Officer: Ensures that safety protocols are followed when deviations involve hazardous materials or conditions that could pose a risk to personnel.
  • 4. Accountability

    The Manufacturing Manager is accountable for ensuring that this SOP is followed and that deviations are properly addressed. The overall compliance with this SOP is under the supervision of the Quality Assurance (QA) Manager.

    5. Procedure

    5.1. Identifying Deviations

    1. Monitor the manufacturing process to identify any deviations that occur. Deviations may include, but are not limited to:
      • Incorrect product formulation
      • Out-of-specification equipment performance (e.g., temperature, pressure)
      • Contamination risks or foreign materials
      • Inconsistent filling volume or packaging
      • Non-compliance with procedural steps
    2. Any employee involved in the manufacturing process can identify and report a deviation. The deviation should be reported to the team leader or supervisor immediately for further evaluation.

    5.2. Documenting Deviations

    1. All deviations should be documented using the Deviation Report Form (Annexure-1). The report should include:
      • Batch number
      • Specific deviation identified
      • Date and time of occurrence
      • Operator or personnel involved
      • Immediate corrective actions taken
      • Potential impact on product quality
    2. The deviation report should be reviewed and signed by the Production Manager or Supervisor to confirm that the issue is being addressed properly.

    5.3. Investigating the Cause of the Deviation

    1. Once a deviation is identified and documented, a thorough investigation should be conducted to determine the root cause of the deviation. The investigation should consider:
      • Equipment malfunction or failure
      • Improper handling or procedural errors
      • Raw material quality or contamination
      • Environmental conditions (e.g., temperature, humidity)
      • Human error or lack of training
    2. Conduct interviews with involved personnel and examine relevant records, equipment, and raw materials to gather information about the cause of the deviation.
    3. The findings of the investigation should be documented in the Investigation Report (Annexure-2).

    5.4. Corrective and Preventive Actions (CAPA)

    1. Once the root cause of the deviation has been identified, appropriate corrective actions must be taken to address the issue and prevent recurrence. These may include:
      • Equipment repairs or recalibration
      • Procedural changes or retraining
      • Adjustments to raw material handling or storage procedures
      • Increased process monitoring or validation steps
    2. Preventive actions should be implemented to ensure that similar deviations do not occur in the future. This may include revising Standard Operating Procedures (SOPs), implementing more stringent quality checks, or improving staff training.
    3. Record all corrective and preventive actions taken in the CAPA Log (Annexure-3) and ensure that these actions are tracked to completion.

    5.5. Verification of Corrective Actions

    1. Once corrective and preventive actions are implemented, conduct follow-up checks to verify that the actions have resolved the issue and that the deviation does not recur.
    2. Monitor the production process closely for the next few batches to ensure that the corrective actions have been effective in preventing further deviations.
    3. Document the results of verification checks and any ongoing monitoring in the Follow-Up Report (Annexure-4).

    5.6. Documentation and Record-Keeping

    1. Ensure that all deviation reports, investigation reports, CAPA logs, and follow-up reports are properly documented and stored in accordance with the company’s document retention policy.
    2. All records related to deviations should be available for review during internal audits or regulatory inspections.
    3. Ensure that all personnel involved in the deviation process are trained on how to complete and maintain the relevant records.

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • CAPA: Corrective and Preventive Actions
    • QC: Quality Control
    • PPE: Personal Protective Equipment
    • R&D: Research and Development

    7. Documents

    1. Deviation Report Form (Annexure-1)
    2. Investigation Report (Annexure-2)
    3. CAPA Log (Annexure-3)
    4. Follow-Up Report (Annexure-4)

    8. References

    This SOP is based on the following regulatory guidelines and industry standards:

    • Good Manufacturing Practice (GMP) Guidelines
    • FDA Code of Federal Regulations (CFR) Title 21, Part 211
    • ISO 9001:2015 – Quality Management Systems
    • International Pharmacopoeia (Ph. Int.) – Aerosol Delivery

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report Form

    Batch No. Deviation Description Action Taken Operator Name Time
    12345 Incorrect product formulation Rework formulation Rajesh Patel 06/02/2025

    Annexure-2: Investigation Report

    Batch No. Investigation Findings Root Cause Operator Name
    12345 Improper ingredient handling Human error Rajesh Patel

    Annexure-3: CAPA Log

    Batch No. Corrective Action Preventive Action Completion Date Operator Name
    12345 Retrained staff on handling Updated SOP for ingredient handling 06/02/2025 Rajesh Patel

    Annexure-4: Follow-Up Report

    Batch No. Follow-Up Findings Action Taken Operator Name
    12345 No recurrence of deviation Monitoring completed Rajesh Patel

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
    01/01/2025 V 2.0 Updated deviation handling procedures To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
    See also  Aerosol: SOP for Managing Safety Data Sheets (SDS) for Aerosol Manufacturing - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Ointments: SOP for Validation of Homogenization – V 2.0
    Next Post: Job Safety Analysis for Wet Granulator

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version